DRS. Remans Reumatologie SRL

DRS. Remans Reumatologie reported total assets of €1.57m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).

By total assets for 2025, DRS. Remans Reumatologie ranks among the 200 largest of the 1,789 companies in its sector (NACE 7499) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0822.082.423 · VAT BE0822082423
3600 Genk
active in Other liberal professions and professional, scientific and technical activities n.e.c. (NACE 74999)
operating since 08 Jan 2010 (≈ 16 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of DRS. Remans Reumatologie shows with a free account.

See the score
Profile
SRL since 2010
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result287,911 €
Equity€1.45m
Cash351,077 €
EBITDA434,659 €
Total assets€1.57m
The line marks its sector median: 57.1% (1041 companies).

Change 2022 → 2025: Equity +43 % Total assets +46 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

DRS. Remans Reumatologie's annual accounts

20252024202320222021
Net result287,911 €
Equity€1.45m
Cash351,077 €
EBITDA434,659 €
Total assets€1.57m

Filed annual accounts

  • Year ended 31 Dec 2025filed on 31 Aug 2026
  • Year ended 31 Dec 2024filed on 30 Jul 2025
  • Year ended 31 Dec 2023filed on 30 Jul 2024
  • Year ended 31 Dec 2022filed on 25 Jul 2023
  • Year ended 31 Dec 2021filed on 30 Jun 2022

DRS. Remans Reumatologie's financial analysis

Management and control of DRS. Remans Reumatologie

1 active director(s) in the register.

DRS. Remans Reumatologie's shareholders and holdings →

DRS. Remans Reumatologie's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0822.082.423
VAT number
BE0822082423
Peppol
Registered · 0208:0822082423 · as of 10 Nov 2026
Legal form
SRL
Incorporated
08 Jan 2010
Registered office
3600 Genk
Latest accounts
2025 · filed on 31 Aug 2026
Activity
Other liberal professions and professional, scientific and technical activities n.e.c. (NACE 74999)

DRS. Remans Reumatologie (SRL) has been based in Genk since 2010, active in: other liberal professions and professional, scientific and technical activities n.e.c.. For 2025, it reports a net profit of 287,911 € and equity of €1.45m; its revenue is not published. Its solvency stands at 92.5%, above the median of its sector (57.1%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to DRS. Remans Reumatologie

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about DRS. Remans Reumatologie

What is the revenue of DRS. Remans Reumatologie?

DRS. Remans Reumatologie files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of DRS. Remans Reumatologie?

In Belgium, the VAT number is the company number prefixed with BE: BE0822082423 for DRS. Remans Reumatologie, if the company is VAT-registered. Its company number (CBE) is 0822.082.423.

Where is the registered office of DRS. Remans Reumatologie?

According to the CBE register, the registered office of DRS. Remans Reumatologie is in 3600 Genk.

What is the equity of DRS. Remans Reumatologie?

At the close of the 2025 financial year, the equity of DRS. Remans Reumatologie amounts to 1,451,007 €, a solvency of 92.5% of total assets.

Who manages DRS. Remans Reumatologie?

The register lists 1 active mandates at DRS. Remans Reumatologie. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is DRS. Remans Reumatologie within its sector?

By total assets for 2025, DRS. Remans Reumatologie ranks among the 200 largest of the 1,789 companies in its sector (NACE 7499) in Belgium that filed accounts for that financial year.

Idonis

The full file of DRS. Remans Reumatologie

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 20 Sep 2026

No credit card, no commitment.

What each plan unlocks →